Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-01 | 2023-02-09 | 176854 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-05-09 | 110719 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-08 | 2023-06-27 | 194125 |
| TEVA-MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-06-21 | 195210 |
| TEVA-MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-09-09 | 2021-12-08 | 145446 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2023-06-20 | 2023-07-06 | 195847 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2017-04-03 | 2017-10-10 | 5216 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Actual shortage | 2023-06-08 | 2024-04-11 | 194157 |
| TEVA-MOXIFLOXACIN | 400MG | TABLET | Resolved | 2020-11-19 | 2021-03-04 | 128603 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-07-10 | 2021-01-14 | 119956 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2022-01-20 | 2023-10-06 | 153171 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2024-11-08 | 2025-01-09 | 242370 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2023-07-04 | 2023-10-04 | 197172 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2023-10-19 | 2023-12-07 | 207539 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-01-20 | 2022-12-02 | 153174 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2019-11-28 | 2019-12-06 | 99947 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2022-12-22 | 2023-01-26 | 179309 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2019-10-17 | 2020-06-26 | 96727 |
| TEVA-MYCOPHENOLATE | 250MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-03 | 107949 |
| TEVA-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2025-12-11 | 2026-01-08 | 274103 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |